MK-2461

· Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK-2461, covering 2015-03-31 to 2015-03-31. Get the full timeline:

Most recent: Clinical Trial Update: MK2461 Phase I/II Study in Patients With Advanced Solid Tumors (MK-2461-002 AM1)(COMPLETED) [Phase 1, Phase 2]